125 filings
Page 4 of 7
D
urf2ks6pug6m
9 Sep 21
$60.1M in equity, sold $60.1M, 27 investors
12:54pm
8-K
n3zj15je0sv
7 Sep 21
Departure of Directors or Certain Officers
5:00pm
D
dvn9flot 25
24 Aug 21
$55M in equity, sold $55M, 81 investors
4:30pm
8-K
6rs20dyyqep5ksfb12q
11 Aug 21
Amwell® Announces Results for Second Quarter 2021
4:11pm
8-K
zk1k19mn7n2kn4o2qn
28 Jul 21
Unregistered Sales of Equity Securities
5:28pm
8-K
zudi9ofdtnc36jb
23 Jul 21
Entry into a Material Definitive Agreement
5:00pm
8-K
kqrq2 m3jyl4m
21 Jun 21
Departure of Directors or Certain Officers
4:31pm
8-K
amtfj 2mv
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:31pm
DEFA14A
67bqyg8 2up
14 May 21
Additional proxy soliciting materials
4:05pm
8-K
zstd8a o1wl341tskx4f
12 May 21
Amwell® Announces Results for First Quarter 2021
4:10pm
DEFA14A
05ljgas0y1rqxwdw5mo
30 Apr 21
Additional proxy soliciting materials
4:09pm
DEF 14A
f3i xsvb760
30 Apr 21
Definitive proxy
4:05pm
10-K
xgw46 352azn
26 Mar 21
Annual report
4:02pm
8-K
uauhe9yn herjac
24 Mar 21
Amwell® Announces Results for Fourth Quarter and Full Year 2020
4:16pm
424B4
fv1e4
15 Jan 21
Prospectus supplement with pricing info
4:21pm
EFFECT
i2ybdd k4
15 Jan 21
Notice of effectiveness
12:15am
8-K
d5cbv8iboxn
12 Jan 21
Results of Operations and Financial Condition
4:41pm